{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:19:28Z","timestamp":1792793968659,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejim.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T11:03:16Z","timestamp":1370343796000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Complement activation in diseases presenting with thrombotic microangiopathy"],"prefix":"10.1016","volume":"24","author":[{"given":"Seppo","family":"Meri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.imbio.2006.01.003","article-title":"Lectin complement system and pattern recognition","volume":"211","author":"Endo","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejim.2013.05.009_bb0015","first-page":"1","article-title":"Human protectin (CD59), an 18,000\u201320,000MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers","volume":"71","author":"Meri","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.ejim.2013.05.009_bb0020","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.molimm.2003.12.002","article-title":"Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?","volume":"40","author":"Blom","year":"2004","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0025","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-0031-1276584","article-title":"C4b-binding protein: a forgotten factor in thrombosis and hemostasis","volume":"37","author":"Dahlback","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2013.05.009_bb0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF01837366","article-title":"Membrane proteins that protect against complement lysis","volume":"15","author":"Morgan","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2013.05.009_bb0040","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0045","doi-asserted-by":"crossref","first-page":"141S","DOI":"10.1111\/1523-1747.ep12876125","article-title":"The human C3b receptor: function and role in human diseases","volume":"94","author":"Tausk","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.1993.tb03377.x","article-title":"CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions","volume":"92","author":"Ross","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00281-005-0002-3","article-title":"Emerging roles and new functions of CD46","volume":"27","author":"Liszewski","year":"2005","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0060","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.147.9.3005","article-title":"Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity","volume":"147","author":"Adams","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0065","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2013.05.009_bb0070","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ejim.2013.05.009_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1196\/annals.1398.011","article-title":"Loss of self-control in the complement system and innate autoreactivity","volume":"1109","author":"Meri","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ejim.2013.05.009_bb0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","article-title":"Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases","volume":"117","author":"Martinon","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2013.05.009_bb0090","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.164.9.4742","article-title":"Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement","volume":"164","author":"Pangburn","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0095","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1073\/pnas.87.10.3982","article-title":"Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid\/polyanion binding site on factor H","volume":"87","author":"Meri","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2013.05.009_bb0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/bbrc.1994.1008","article-title":"Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H","volume":"198","author":"Meri","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejim.2013.05.009_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4049\/jimmunol.122.1.75","article-title":"Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b","volume":"122","author":"Kazatchkine","year":"1979","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0110","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.4049\/jimmunol.160.7.3342","article-title":"Identification of the second heparin-binding domain in human complement factor H","volume":"160","author":"Blackmore","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0115","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.1017087108","article-title":"Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement","volume":"108","author":"Kajander","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2013.05.009_bb0120","doi-asserted-by":"crossref","first-page":"27657","DOI":"10.1074\/jbc.M002903200","article-title":"Each of the three binding sites on complement factor H interacts with a distinct site on C3b","volume":"275","author":"Jokiranta","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2013.05.009_bb0125","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1084\/jem.163.5.1064","article-title":"Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening","volume":"163","author":"Miettinen","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0162-3109(99)00015-6","article-title":"The factor H protein family","volume":"42","author":"Zipfel","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejim.2013.05.009_bb0135","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0065-2776(08)60697-5","article-title":"The regulators of complement activation (RCA) gene cluster","volume":"45","author":"Hourcade","year":"1989","journal-title":"Adv Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H","volume":"151","author":"de Cordoba","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0150","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.05.009_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.imbio.2011.10.003","article-title":"Complement factor H-ligand interactions: self-association, multivalency and dissociation constants","volume":"217","author":"Perkins","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejim.2013.05.009_bb0160","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.4049\/jimmunol.163.7.3957","article-title":"Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11","volume":"163","author":"Jarva","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0165","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.4049\/jimmunol.181.12.8433","article-title":"Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation","volume":"181","author":"Deban","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejim.2013.05.009_bb0175","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejim.2013.05.009_bb0180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197602262940902","article-title":"The complement abnormalities of lipodystrophy","volume":"294","author":"Sissons","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0185","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2013.05.009_bb0190","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0195","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1055\/s-0030-1262886","article-title":"Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes","volume":"36","author":"Le Quintrec","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ejim.2013.05.009_bb0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/MOH.0b013e32833cae86","article-title":"Atypical hemolytic uremic syndrome","volume":"17","author":"Kavanagh","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0205","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/j.molimm.2007.06.003","article-title":"Where next with atypical hemolytic uremic syndrome?","volume":"44","author":"Jokiranta","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0210","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.05.009_bb0215","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0220","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"DGKE variants cause a glomerular microangiopathy that mimics membranoproliferative GN","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic\u2013uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejim.2013.05.009_bb0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0235","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","article-title":"Complement activation on platelets: implications for vascular inflammation and thrombosis","volume":"47","author":"Peerschke","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0240","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0245","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2013.05.009_bb0250","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.009_bb0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2013.05.009_bb0260","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/eji.1830221029","article-title":"Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene","volume":"22","author":"Motoyama","year":"1992","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ejim.2013.05.009_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2012-07-441857","article-title":"CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy","volume":"121","author":"Nevo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.05.009_bb0270","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","author":"Hill","year":"2013","journal-title":"Blood"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T05:21:40Z","timestamp":1688275300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0953620513001374"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement activation in diseases presenting with thrombotic microangiopathy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}